Evaluating providers

How to evaluate an ibogaine treatment center.

Standards in this field vary enormously, and the marketing does not distinguish them. These are the questions worth asking any provider — including us. Nothing here is a rating of specific facilities; it is a framework for making an informed decision.

Written by
Johnny Tabaie
Founder, Holistic Sanctuary
Medically reviewed by
Holistic Sanctuary Medical Team
Attending physician and nursing leadership
Published
3 September 2026
Last reviewed
3 September 2026

Why this matters

Most documented harm involves inadequate setting.

Reviews of ibogaine-associated fatalities repeatedly identify the same context: pre-existing cardiac disease that was not detected, interacting medication that was not reviewed, concurrent substance use, and administration without medical monitoring or the means to respond to an arrhythmia. The compound's risk profile is real, and the setting substantially determines whether that risk is managed or simply accepted.

This is why choosing a provider is not a matter of comfort, cost or atmosphere. The questions below are about whether identifiable risks are being looked for and whether there is a plan if something goes wrong.

A note on our own position

We operate a private facility, so we are not a neutral party. That is exactly why this page names criteria rather than facilities, and why we would rather you use it to interrogate us than accept a claim. If a question here produces an unsatisfactory answer from any provider, that is useful information.

Before you contact anyone

Read the safety considerations and speak to your own physician. Do not discontinue prescribed medication in order to qualify for treatment anywhere.

Checklist

Twelve questions to ask.

  1. 01

    Cardiac screening

    Ask whether a baseline ECG with QTc measurement is mandatory before administration, who reads it, and what findings result in decline. A provider that cannot describe its exclusion criteria does not have any.

  2. 02

    Emergency preparedness

    Ask what happens if an arrhythmia occurs: what monitoring is in place, what equipment and medication are on site, who is trained to use them, and how far away the nearest hospital with cardiac capability is.

  3. 03

    Qualified personnel

    Ask which licensed clinicians are physically present during administration and for the hours afterwards, what their credentials are, and whether that presence is continuous or intermittent.

  4. 04

    Medical monitoring

    Ask what is monitored, at what intervals, and for how long after administration. Cardiac monitoring that stops when the acute phase ends does not match the pharmacology of a long-lived metabolite.

  5. 05

    Written protocols and consent

    Ask to see the screening protocol and the consent document before you travel. Consent that names serious adverse events and the possibility of death is a sign of seriousness, not a warning sign.

  6. 06

    Honesty about evidence

    Ask directly what the evidence base is. An accurate answer includes that no completed randomized controlled trials exist and that outcomes vary. Any provider claiming a cure, a guaranteed result, a perfect safety record or a brain reset is telling you something the literature does not support.

  7. 07

    Medication handling

    Ask how prescribed medication is reviewed, who liaises with your existing prescriber, and how interacting drugs are managed. A provider that tells you to stop your medication before arriving on your own is a serious concern.

  8. 08

    Screening rigour

    Ask how often people are declined. A provider that accepts effectively everyone who can pay is not screening, whatever it calls the process.

  9. 09

    Aftercare

    Ask what happens after discharge — whether continuing care is arranged, whether there is any follow-up contact, and whether outcomes are tracked at all.

  10. 10

    Legal and regulatory status

    Ask under what legal framework and licensing the facility operates in its jurisdiction. Ibogaine's legal status varies by country and it is not approved for treatment in the United States.

  11. 11

    Cost transparency

    Ask what is and is not included, in writing, including the cost consequences of being declined at screening or of a longer stay.

  12. 12

    How they respond to questions

    The most informative signal is often the response to this list. Discomfort at being asked about emergency equipment is itself an answer.

References

Primary sources.

  1. 01Alper KR, Stajić M, Gill JR. Fatalities temporally associated with the ingestion of ibogaine. J Forensic Sci (2012). Source
  2. 02Koenig X, Hilber K. The anti-addiction drug ibogaine and the heart. Molecules (2015). Source
  3. 03Litjens RPW, Brunt TM. How toxic is ibogaine? Clin Toxicol (2016). Source
  4. 04US Food and Drug Administration — Psychedelic drugs: considerations for clinical investigations. Source

Related

Ibogaine

Ibogaine Treatment

A comprehensive, evidence-led resource on ibogaine: pharmacology, the research base, cardiac risk, candidacy, preparation and integration.

Ibogaine

Best Ibogaine Treatment Centers

A consumer guide to evaluating an ibogaine provider: screening, cardiac assessment, medical oversight, emergency preparedness and transparency.

Ibogaine

Ibogaine Safety

QT prolongation, arrhythmia risk, CYP2D6 metabolism, drug interactions and electrolytes — what the safety literature establishes and what remains uncertain.

Ibogaine

Ibogaine Integration

Why the weeks after an experience matter: reflection, behavior, sleep, nutrition, relationships, meaning and ongoing professional support.

Insights

Latest Insights

Browse all insights

Benzodiazepine Treatment

Benzodiazepine Detox

Benzo detox and withdrawal treatment: a physician-directed taper, twenty-four hour monitoring, nine hours of daily therapy and the in-house Brain Repair IV protocol.

Ibogaine

Best Ibogaine Treatment Centers

A consumer guide to evaluating an ibogaine provider: screening, cardiac assessment, medical oversight, emergency preparedness and transparency.

Benzodiazepine Treatment

Holistic Benzodiazepine Treatment

Physician-supervised benzodiazepine detox and withdrawal support: gradual tapering, nine hours of daily one-to-one therapy, the in-house Brain Repair IV protocol, and whole-body restoration in a private oceanfront setting.

Mental Health

Holistic Mental Health Treatment

An integrative approach to PTSD, trauma, depression and anxiety that treats sleep, nutrition, environment and behavior as clinical variables.

Holistic Treatment

Holistic Rehab

Rehabilitation as system repair: mental health, behavior, environment, nutrition and sleep, with specialized medical support where it is needed.

Ibogaine

Ibogaine Integration

Why the weeks after an experience matter: reflection, behavior, sleep, nutrition, relationships, meaning and ongoing professional support.

Ibogaine

Ibogaine Preparation

Medical, psychological and practical preparation: history, medication review, ECG, laboratory assessment, consent and integration planning.

Ibogaine

Ibogaine Safety

QT prolongation, arrhythmia risk, CYP2D6 metabolism, drug interactions and electrolytes — what the safety literature establishes and what remains uncertain.

Ask us these questions.

Admissions is a confidential clinical conversation, not a sales call. We review history, current medication, and goals before anyone is accepted.